* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Lesions, Swelling, Pain and Dysfunction: Men’s Health Update
Survey
Document related concepts
Transcript
Lesions, Swelling, Pain and Dysfunction: Men’s Health Update Thomas W. Barkley, Jr., DSN, ACNP-BC Associate Professor of Nursing Director of Graduate and Nurse Practitioner Programs California State University, Los Angeles and President, Barkley & Associates www.NPcourses.com ©2009 Barkley & Associates I have no current affiliation or financial arrangement with any grantor or commercial interests that might have direct interest in the subject matter of this CE Program. ©2009 Barkley & Associates Objectives Identify common disorders requiring specific pharmacotherapy for select male conditions Recognize common pharmacologic agents prescribed for select male conditions State differences between select male conditions and various pharmacologic therapies specific to each ©2009 Barkley & Associates 9.3.42 Lesions, Swelling, Pain and Dysfunction: Men’s Health Update Topical Outline Epididymitis Prostatitis Balanitis Benign Prostatic Hypertrophy (BPH) Prostate Cancer Erectile Dysfunction Men’s STIs/STDs Update: Herpes Genitalis Genital Warts Chlamydia Gonorrhea Syphilis Chancroid LGV ©2009 Barkley & Associates Men’s Reproductive System 1. Prostate gland: Produces a fluid which forms part of the semen (the liquid which appears as ejaculate) 2. Seminal vesicles: Sit at the back of the prostate gland; produce the thick milky fluid of the semen 3. Vas deferens: Tube which carries sperm from the testicles to the urethra 4. Scrotum: Sac which hold the testicles 5. Urethra: Tube which carries urine from the bladder and semen through the penis ©2009 Barkley & Associates Men’s Reproductive System 6. Penis: Made up of spongy tissue which fills with blood during an erection 7. Foreskin: Covers the glans and can be pulled back for cleaning - this is removed when a man is circumcised 8. Glans: Helmet shaped head of the penis 9. Epididymis: Area where sperm are stored in the testicles 10. Testicles: Produce sperm and the male sex hormone testosterone ©2009 Barkley & Associates 9.3.42 Epididymitis ©2009 Barkley & Associates Epididymitis Inflammatory reaction of the epididymis caused by either an infectious agent or local trauma Exclusive to males of all ages, but usually found in sexually active men or older males > 600,000 case reported yearly May be caused by congenital urologic structural disorders with possible pre-disposition to infections ©2009 Barkley & Associates Epididymitis - Symptoms Dysuria Urgency Frequency Low back/perineal pain Fever/chills Malaise Scrotal edema* ©2009 Barkley & Associates 9.3.42 ©2009 Barkley & Associates Epididymitis: Signs/Symptoms Tender/painful swelling of the scrotum with erythema Unilateral testicular pain & tenderness + Phren’s test Urethral discharge and/or dysuria Hydrocele or epididymoorchitis (late in condition) ©2009 Barkley & Associates Epididymitis Male reproductive organs 1 Ductus deferens 2 Epididymis 3 Testicle Examples of Epididymitis ©2009 Barkley & Associates 9.3.42 Causes & Underlying Factors Young, prepubertal boys: > 35 yrs or with underlying urologic disease: Coliform Bacteria Gram-negative aerobic rods Almost always as a complication of urologic disease Mycobacteria Young, sexually active men: Chlamydia trachomatis Neisseria Gonorrhoeae Note: Diabetics are especially prone to develop extensive scrotal infections, including Fournier’s gangrene. AIDS Patients: CMV & Salmonella epididymitis Toxoplasmosis: always to be considered as cause ©2009 Barkley & Associates Complications Atrophy of the affected testicle Scrotal abscess Chronic epididymitis Rarely: impaired fertility Epididymoorchitis ©2009 Barkley & Associates Types of Epididymitis Bacterial Non Bacterial Tuberculosis Fungal ©2009 Barkley & Associates 9.3.42 Bacterial Epididymitis Usually results from an infection spreading to the epididymis from other urogenital organs (e.g., prostate, bladder, kidney, etc.) Quick onset (< 24 hours) ©2009 Barkley & Associates Other (Non-Bacterial) Epididymitis Viral: usually with a very quick onset Trauma: initially not associated with fever and generalized symptoms Idiopathic: unknown cause, usually not associated with fever; perhaps caused by rupture of the sperm ducts, causing sperm to leak into the tissue ©2009 Barkley & Associates Treatment Pharmacologic: Analgesics Antibiotics Non-Pharmacologic: Ice packs Scrotal elevation Bed rest Surgical aspiration ©2009 Barkley & Associates 9.3.42 Pharmacologic Treatment: Analgesics Acetaminophen with or without Codeine: For relief of pain and discomfort NSAIDs: Ibuprofen ©2009 Barkley & Associates Pharmacologic Treatment: Epididymitis Antibiotics In sexually active men: Active agents against N. Gonorrhoeae and Chlamydia should always be included in treatment Ceftriaxone 250 mg IM single dose + Doxycycline 100 mg PO BID x 10 days Azithromycin 1 gm PO single dose If > 35 years of age (older men), consider: Ofloxacin 300 mg p.o. BID x 10 days Levofloxacin 500 mg p.o. every day x 10 days ©2009 Barkley & Associates Prostatitis ©2009 Barkley & Associates 9.3.42 Prostatitis 50% of men experience symptoms of prostatitis in their lifetime ~ 2 million physician visits per year, included a diagnosis of prostatitis Inflammation of the prostate gland Characterized by perineal pain and irregular urination and (if severe) chills and fever ©2009 Barkley & Associates Acute Bacterial Prostatitis Infection of the prostate Causative agents: Gram negative bacteria, E. Coli Nonbacterial prostatitis – young men Chlamydia Mycoplasma Gardnerella ©2009 Barkley & Associates Acute Bacterial Prostatitis Presentation/Exam Fever/Chills Low back pain Dysuria Urgency Frequency Nocturia Prostate – Warm Tender to palpation Firm or Boggy ©2009 Barkley & Associates 9.3.42 Acute Bacterial Prostatitis Diagnostic Tests Urine culture – positive for causative agent ©2009 Barkley & Associates Acute Bacterial Prostatitis – Management Hospitalization if septicemia or urinary retention is suspected Possible agents: Trimethoprim Sulfamethoxizole (Bactrim) Ofloxacin Ciprofloxacin Chronic: Finasteride (Proscar) – lowers the amount of testosterone; prostate shrinks; SE: less interest in sex and erectile/ejaculation problems Sitz bath TID for 30 minutes each treatment No sexual intercourse until acute phase resolves ©2009 Barkley & Associates Balanitis ©2009 Barkley & Associates 9.3.42 Balanitis Inflammation of the superficial tissues of the penile head (glans penis) Exclusive to males of all ages, especially sexually active men Uncircumcised men are more at risk for balanitis due to the presence of the foreskin Most of the organisms associated with balanitis are already present on the penis, but in very small numbers ©2009 Barkley & Associates Balanitis Moist and scattered lesion of balanitis Dry scaly, confluent lesion of balanitis ©2009 Barkley & Associates Symptoms of Balanitis Itching and tenderness Pain, local edema and dysuria Urethritis with or without discharge Painful erection with altered sexual function Rarely: severe ulcerations which may lead to superimposed bacterial infections Rarely: lymph node enlargement ©2009 Barkley & Associates 9.3.42 Balanitis: Causes & Risk Factors Poor hygiene Sexual contact Urinary catheters Trauma (frictional or accidental wounds) Allergic reaction to chemical irritants (e.g., soap, lubricant jelly, condoms, etc.) Allergic reaction to medications Obesity ©2009 Barkley & Associates Types of Balanitis Candidal Trichomonal Mycoplasma Chlamydial Anaerobic ©2009 Barkley & Associates Candidal Balanitis Most common type Frequently follows intercourse with an infected partner Also occurs without sexual contact in diabetic patients or patients taking oral antibiotics Recurrent candidal balanitis causes fissuring of the prepuce, with fibrosis and sclerosis ©2009 Barkley & Associates 9.3.42 Treatment Pharmacologic: Analgesics Ointment & Creams Topical corticosteroids Antibiotics Non-Pharmacologic: Meticulous hygiene maintenance Warm sitz baths Circumcision ©2009 Barkley & Associates Balanitis: Non-Pharmacologic Treatment Hygiene: Warm sitz baths: Retraction and bathing of prepuce several times daily If a Foley catheter is used: strict catheter care Ease edema and erythema Circumcision: Consider if symptoms are severe or recurrent May be necessary if phimosis or meatitis occurs Note: Severe phimosis may require prompt slit drainage, if unable to void ©2009 Barkley & Associates Pharmacologic Treatment: Analgesics Acetaminophen: for minor pain and fever caused by the skin irritation and infection AND/OR Codeine: for patients with more severe cases or low pain threshold ©2009 Barkley & Associates 9.3.42 Pharmacologic Treatment Clotrimazole 1% cream: topical cream; kills fungi and yeasts by interfering with their cell membranes Applied to affected areas TID Bacitracin ointment: Topical antibiotic used to treat and prevent bacterial infections. >Applied to affected areas 3 to 4 times daily Topical Corticosteroids: QID for severe dermatitis Betamethasone: apply thin film BID ©2009 Barkley & Associates Balanitis: Considerations Always assess for evidence of other STDs in sexually active men If lesions do not heal, refer for biopsy (i.e., premalignant/malignant lesions, carcinoma of the penis, etc.) When possible, always treat underlying cause to avoid future recurrences Even though uncircumcised men are at a higher risk, there is no significant difference in the rate of occurrence, compared to those who are circumcised ©2009 Barkley & Associates Benign Prostatic Hypertrophy (BPH) ©2009 Barkley & Associates 9.3.42 Benign Prostatic Hypertrophy (BPH) Progressive, benign hyperplasia of prostate gland tissue By 50 years, ~ 50% of men By 80 years, ~ 80%-90% of men Etiology is unknown The most common cause of bladder obstruction in men over the age of 50 years ©2009 Barkley & Associates BPH – Symptoms (He’s got the ‘goes’ - maybe) Frequency Urgency Nocturia Dribbling Retention ©2009 Barkley & Associates ©2009 Barkley & Associates 9.3.42 BPH – Physical Exam Bladder distention may be present Prostate is nontender with either asymmetrical or symmetrical enlargement Smooth, rubbery consistency with possible nodules ©2009 Barkley & Associates BPH – Diagnostic Tests U/A - rules out UTI, no hematuria Uroflowmetry Abdominal ultrasound - rule out upper tract pathology Serum creatinine/BUN normal American Urological Association-International Prostate Symptom Score (AUA/IPSS) ©2009 Barkley & Associates BPH – Diagnostic Tests PSA Normal Levels (Age-specific ranges based on having had a previous PSA < 4 ng/mL) Age 40-49 years: < 2.5 ng/mL Age 50-59 years: < 3.5 ng/mL Age 60-69 years: < 4.5 ng/mL Age 70-79 years: < 6.5 ng/mL ©2009 Barkley & Associates 9.3.42 BPH – Diagnostic Tests Major Reasons for PSA Elevation: Prostate Cancer Prostate Enlargement Prostatitis ©2009 Barkley & Associates Relative Risk of Prostate Enlargement by PSA Level (Wright et al., 2002; http://www.avodart.com/m07_01.html) ©2009 Barkley & Associates BPH – Management Observe: Watchful waiting Consult/refer as needed Medications to decrease bulk and/or tone of gland Alpha-blockers 5-alpha-reductase inhibitors Combination therapy Herbal preparations (saw palmetto?) – not FDA regulated Minimally invasive procedures (numerous) Surgery ©2009 Barkley & Associates 9.3.42 BPH Pharmacotherapy Alpha adrenergic blockers Originally developed to treat HTN Relax smooth muscle in the prostate and around the bladder neck Similar efficacy Best for normal-sized to moderately enlarged prostates Hytrin terazosin Cardura doxazosin Flomax tamsulosin Uroxatral alfuzosin Minipress prazosin ©2009 Barkley & Associates Alpha adrenergic blockers See effects within ~ 1-2 days (increased urinary flow; urinate less often) Often 4 to 6 point decrease in urinary symptom index score Major Side Effects: Decreased ejaculate Low blood pressure Dizziness Headache Stomach or intestinal irritation Stuffy nose ©2009 Barkley & Associates Alpha adrenergic blockers Warnings/Considerations: Risk of intraoperative floppy iris syndrome (IFIS) in patients taking tamsulosin (Flomax) or others IFIS – characterized by the iris not responding appropriately during cataract surgery Can lower blood pressure to unhealthy levels when taken with erectile dysfunction drugs such as sildenafil (Viagra), vardenafil (Levitra) and tadalafil (Cialis) Follow up every 3-6 months during the first year of therapy ©2009 Barkley & Associates 9.3.42 Enzyme (5-alpha-reductase) inhibitors for BPH Shrink the prostate Reduces the amount of testosterone that turns into dihydrotestosterone (DHT), a hormone required for prostate gland growth Attaches to receptors on the prostate cells; encourages them to grow/multiply Inhibitors reduce the prostate's "appetite" for DHT by reducing the number of receptor sites where DHT can attach Finasteride (Proscar) Dutasteride (Avodart) ©2009 Barkley & Associates 5-alpha-reductase inhibitors for BPH Equally effective Take longer to work ~ 3 – 6 months More costly than alpha blockers Increase urine flow rate Reduce urinary symptom index scores by an average of 3 points ©2009 Barkley & Associates 5-alpha-reductase inhibitors for BPH With moderate disease to severe disease, may significantly decrease the need for surgery and the incidence of urinary retention Major Side Effects: Erection problems Decreased sexual desire Reduced semen release during ejaculation Side effects may cease when meds are discontinued or after ~ 1 year of therapy ©2009 Barkley & Associates 9.3.42 How safe are the newer 5-alphareductase inhibitors? ©2009 Barkley & Associates Dutasteride (Avodart) Contraindications: Women and children Patients with known hypersensitivity to 5-reductase inhibitors Warnings/Precautions: Dutasteride is absorbed through the skin Women who are pregnant or may be pregnant should not handle Avodart Soft Gelatin Capsules because of the possibility of absorption of dutasteride and the potential risk of a fetal anomaly to a male fetus (feminization; decreased anogenital distance, nipple development, hypospadias) Women should use caution whenever handling; if contact is made with leaking capsules, the contact area should be washed immediately with soap and water ©2009 Barkley & Associates Dutasteride (Avodart) Men being treated should not donate blood until at least 6 months have passed following their last dose. Purpose: prevent administration of dutasteride to a pregnant female transfusion recipient Hepatic impairment – not studied PSA reestablished after 6 months – isolated should be doubled after 6 months for comparison to prestudy baseline ©2009 Barkley & Associates 9.3.42 Dutasteride (Avodart) Adverse events: Impotence Decreased libido Ejaculation disorders Gynecomastia ©2009 Barkley & Associates Alpha blockers + 5-alpha-reductase inhibitors Combination Therapy for BPH Most tested: doxazosin + finasteride One study found this combination to significantly reduce the risk of further prostate enlargement to the point where invasive surgery was not needed Works best for those with large prostates and high PSAs Side effects – assumed similar to the combination effect (not significantly studied) ©2009 Barkley & Associates Saw palmetto Medicinal element taken from the partially dried ripe fruit of the American dwarf palm tree Studies shown effectiveness in reducing BPH symptoms Appears to have efficacy similar to that of finasteride No known drug interactions Not FDA regulated (Gordon & Shaughnessy, 2003) ©2009 Barkley & Associates 9.3.42 Prostate Cancer ©2009 Barkley & Associates PROSTATE CANCER Most common form of cancer, other than skin cancer, among men in the United States # 2 cause of cancer-related death among men About 70% of all diagnosed prostate cancers are found in men aged 65 years or older Over the past 20 years, the survival rate for prostate cancer has increased from 67% to 97% Death rate higher for African-American men than for any other racial or ethnic group Cause unknown; High-fat diets are implicated ©2009 Barkley & Associates Symptoms ASYMPTOMATIC May appear to be BPH In later stages: Bone pain Uremia ©2009 Barkley & Associates 9.3.42 Prostate Cancer - Examination Adenopathy Bladder distension Prostate palpates harder than normal ©2009 Barkley & Associates Prostate Cancer –Tests Prostate-specific antigen (PSA) > 4 abnormal Approximately 40% of prostate cancer patients present with normal PSA values! (not a very sensitive test!) ©2009 Barkley & Associates Prostate Cancer – Management Consult/refer Accurate staging is critical Watchful waiting… Treatment options include surgery, radiation, and/or hormone therapy ©2009 Barkley & Associates 9.3.42 Erectile Dysfunction ©2009 Barkley & Associates Erectile Dysfunction (ED) Inability to achieve and sustain an erection suitable for sexual intercourse ~ 52% of men aged 40-70 have ED ~ 5% of 40-year-old men and 15-25% of 65-year-old men experience ED on a long-term basis Not considered “normal” at any age! ©2009 Barkley & Associates What Causes Erectile Dysfunction? For an erection to occur: Nerves to the penis must be properly functioning Blood circulation to the penis must be adequate Must be a stimulus from the brain Common causes: atherosclerosis, nerve diseases, psychological factors/stress, depression, performance anxiety, penile injury and medications ©2009 Barkley & Associates 9.3.42 Causes of ED: Diuretics & Antihypertensives Hydrochlorothiazide (Esidrix, HydroDIURIL, Lotensin) Triamterene (Maxide, Dyazide) Furosemide (Lasix) Bumetanide (Bumex) Methyldopa (Aldomet) Clonidine (Catapres) Verapamil (Calan, Isoptin, Verelan) Nifedipine (Adalat, Procardia) Hydralazine (Apresoline) Captopril (Capoten) Enalapril (Vasotec) Metoprolol (Lopressor) Propranolol (Inderal) Labetalol (Normodyne) Atenolol (Tenormin) Phenoxybenzamine (Dibenzyline) Spironolactone (Aldactone) ©2009 Barkley & Associates Causes of ED: Antidepressants, anti-anxiety and antiepileptic drugs Fluoxetine (Prozac) Tranylcypromine (Parnate) Sertraline (Zoloft) Isocarboxazid (Marplan) Amitriptyline (Elavil) Amoxipine (Asendin) Clomiprimine (Anafranil) Desipramine (Norpramin) Nortriptyline (Pamelor) Phenelzine (Nardil) Buspirone (Buspar) Chlordiazepoxide (Librium) Clorazepate (Tranxene) Diazepam (Valium) Doxepin (Sinequan) Imipramine (Tofranil) Lorazepam (Ativan) Oxazepam (Serax) Phenytoin (Dilantin) ©2009 Barkley & Associates Causes of ED: Antihistamines Dimehydrinate (Dramamine) Diphenhydramine (Benadryl) Hydroxyzine (Vistaril) Meclizine (Antivert) Promethazine (Phenergan) ©2009 Barkley & Associates 9.3.42 Causes of ED NSAIDS Naproxen (Anaprox, Naprelan, Naprosyn) Indomethacin (Indocin) Muscle Relaxants Cyclobenzaprine (Flexeril) Orphenadrine (Norflex) Anti-arrythmics Disopyramide (Norpace) ©2009 Barkley & Associates Causes of ED H-2 Receptor Antagonists Cimetidine (Tagamet) Nizatidine (Axid) Ranitidine (Zantac) Parkinson’s Disease Medications Biperiden (Akineton) Benztropine (Cogentin) Trihexyphenidyl (Artane) Procyclidine (Kemadrin) Bromocriptine (Parlodel) Levodopa (Sinemet) ©2009 Barkley & Associates Causes of ED Recreational Drugs Alcohol Amphetamines Barbiturates Cocaine Marijuana Methadone Nicotine Opiates ©2009 Barkley & Associates 9.3.42 Erectile Dysfunction: Treatment Medication choices: sildenafil (Viagra) vardenafil (Levitra) tadalafil (Cialis) …known as the phosphodiesterase inhibitors ©2009 Barkley & Associates Phosphodiesterase (PDE) inhibitors Prevent the breakdown of nitric oxide, a chemical messenger that promotes relaxation and opening of the blood vessels that supply erectile tissue in the penis Under the influence of nitric oxide, these vessels expand and stay dilated Increased blood flow makes erectile tissue swell and compress the veins that carry blood out of the penis, resulting in a full erection ©2009 Barkley & Associates Phosphodiesterase (PDE) inhibitors Sildenafil (Viagra) Vardenafil (Levitra) Tadalafil (Cialis) Works? 30 minutes 60 mins 15 minutes Lasts? 4 hours 4 hours up to 36 hours Usual 50 mg/d Dose? Max Dose? 100 mg/d 10 mg /d 10 mg/d 20 mg/d 20 mg/d Take? Without food Without food With or without food Available? 20, 25, 50, 100 mg 2.5, 5, 10, 20 mg 5, 10, 20 mg ©2009 Barkley & Associates 9.3.42 Erectile Dysfunction: BREAKING NEWS New ED Drugs On The Way! (DeNoon & Chang, 2006) One works fast One lasts long One promises to be the next best thing to a cure! ©2009 Barkley & Associates Erectile Dysfunction Near a Cure for Erectile Dysfunction? For now, it is called hMaxi-K Suitably enough for an erection treatment, it is a form of gene therapy called naked DNA Its DNA carries a human genetic code into target cells When the cell reads this code, it makes a protein. In the case of hMaxi-K, it is a protein that tells smooth muscles to relax ©2009 Barkley & Associates Erectile Dysfunction First human trial (Melman, 2006) reported 11 men with erectile dysfunction received injections of the gene therapy directly into the penis Because this was the first human study, the doses used were smaller than those expected to have a true effect on erections The study was successful in two ways: It was safe Two men who received higher doses of hMaxi-K had greatly improved erections -- which occurred only during sexual arousal -- for six months after a single treatment! ©2009 Barkley & Associates 9.3.42 Erectile Dysfunction Additional Findings: Sex doesn’t have to be planned – allows one to get a normal erection whenever aroused hMaxi-K will also be effective for a wide range of diseases that arise from the failure of smooth muscle to relax Overactive bladder Asthma Irritable bowel syndrome BPH Premature labor Premenstrual syndrome ©2009 Barkley & Associates Erectile Dysfunction Long Acting Erection Drug, SLx-2101 (Goldstein, 2006) Like Viagra, Cialis, and Levitra, SLx-2101 works by inhibiting an enzyme that makes smooth muscles contract Unlike other approved erection drugs, SLx-2101 is two drugs in one: When first taken, SLx-2101 is a powerful erection drug While it is still working, the body begins to process it into a second drug, SLx-2101m1, also a powerful erection drug Acts well beyond 48 hours Interestingly, SLx-2101 improves erections not only in men with ED, but also in men already able to have erections! (woo hoo!!) ©2009 Barkley & Associates Erectile Dysfunction Faster, Shorter-Acting Erection Drug (Nehra, 2006) Avanafil Avanafil reaches maximum blood concentrations 35 minutes after it is taken It has a half-life of 90 minutes (Compared with 4 hours for Levitra and Viagra and 17.5 hours for Cialis) Good for personal preferences and men who take nitrate-based drugs (e.g., Nitrostat, Isordil, and Imdur) Men taking a nitrate-based drug while on avanafil had less of a drop in blood pressure and less of an increase in blood pressure than men who took the heart drug while on Viagra ©2009 Barkley & Associates 9.3.42 Men’s STDs/STIs Update ©2009 Barkley & Associates Herpes Genitalis ©2009 Barkley & Associates Herpes Genitalis Cause: Herpes simplex virus (HSV) types 1 and 2 90-95% of genital herpes caused by type 2 Prevalence: Primary infections ~ 200,000 annually Recurrent infections more common Estimated > 45 million Americans infected 1/5 adolescents (> 12 years old) and adults infected ©2009 Barkley & Associates 9.3.42 Genital Herpes: Initial Visits to Physicians’ Offices (1996-2004) http://www.cdc.gov/std/stats/tables/table47.htm 300,000 269,000 250,000 208,000 200,000 1966 150,000 136,000 1976 1986 1996 2004 100,000 56,000 50,000 19,000 0 ©2009 Barkley & Associates Herpes Genitalis: Presentation Pruritic vesicles Vesicles rupture to form shallow ulcers Resolve spontaneously Viral shedding occurs intermittently without clinical symptoms Inguinal adenopathy present with initial case Fever/chills Headache Malaise Dysuria Dyspareunia ©2009 Barkley & Associates ©2009 Barkley & Associates 9.3.42 Genital Herpes What about asymptomatic viral shedding, especially in discordant couples? ©2009 Barkley & Associates Genital Warts ©2009 Barkley & Associates GENITAL WARTS Single or multiple soft, fleshing, papillary or sessile, painless keratinized growth around anus, penis, urethra or perineum ©2009 Barkley & Associates 9.3.42 GENITAL WARTS (Condyloma acuminata) Cause: Human papillomavirus (HPV) Prevalence: The most common symptomatic viral STD in U.S. Accounts for > than 1 million office visits per year Estimated 3 million cases of HPV are reported annually ©2009 Barkley & Associates GENITAL WARTS (Condyloma acuminata) Over ½ of sexually active men in the U.S. will have HPV at some time in their lives ~ 1% of sexually active men in the U.S. have genital warts at any one time The incidence of penile cancer is increasing In this country, penile cancer accounts ~ 0.2% of all cancers in men (especially rare in circumcised men) ~ 1,910 men will be diagnosed with anal cancer in 2006 Risk is 17 times higher among gay and bisexual men, as well as those with compromised immune systems (HIV) ©2009 Barkley & Associates GENITAL WARTS Treatment Remove warts Cryosurgery Trichloroacetic acid (TCA) Bichloroacetic acid (BCA) Laser treatment No therapy has been shown to completely eradicate HPV ©2009 Barkley & Associates 9.3.42 Chlamydia ©2009 Barkley & Associates Chlamydia: Signs/Symptoms Males Often Asymptomatic Urethral discharge Dysuria Testicular pain and/or swelling Inguinal adenopathy ©2009 Barkley & Associates Chlamydia Treatment: Azithromycin (Zithromax) 1 g p.o. x 1 dose Doxycycline (Adoxa) 100 mg p.o. BID x 7-10 days NOTE: Due to high rate of coexistence with gonorrhea, both diseases are commonly treated simultaneously Ceftriaxone 125 mg IM x 1 dose Report to Health Department (in most states) ©2009 Barkley & Associates 9.3.42 Gonorrhea ©2009 Barkley & Associates Gonorrhea Cause: Neisseria gonorrheae, a gram-negative diplococcus Prevalence: Most commonly reported communicable disease in the United States Estimated 1.5 million per year ©2009 Barkley & Associates Gonorrhea: Symptoms Dysuria Increased frequency of urination Purulent urethral discharge Testicular pain Many to most patients may be asymptomatic ©2009 Barkley & Associates 9.3.42 Gonorrhea Diagnosis: DNA probe or culture Treatment: Ceftriaxone (Rocephin) 125 mg IM x 1 dose Report to the health department ©2009 Barkley & Associates Syphilis ©2009 Barkley & Associates Syphilis Cause: Treponema pallidum, a spirochete with 6 to 14 regular spirals Prevalence: 40,000 cases annually in the United States Highest level in the past 40 years ©2009 Barkley & Associates 9.3.42 Syphilis: Symptoms Primary: Chancre is painless Indurated ulcer Located at the site of exposure Secondary: Highly variable skin rash on palmar and plantar surfaces Mucous patches Condylomata lata Lymphadenopathy Malaise Anorexia Alopecia Arthralgias ©2009 Barkley & Associates Syphilis: Symptoms Latent: Seropositive Asymptomatic Tertiary: Leukoplakia Cardiac insufficiency Aortic aneurysm Meningitis Hemiparesis Hemiplegia ©2009 Barkley & Associates Syphilis Chancre ©2009 Barkley & Associates 9.3.42 Secondary syphilis - palms and soles ©2009 Barkley & Associates Syphilis Serologic Tests: Nontreponemal: Treponemal FTA-ABS VDRL/RPR tests: (fluorescent treponemal antibody absorption MHA-TP (microhemaglutination assay for antibody to T. pallidum) ©2009 Barkley & Associates Syphilis: Treatment Primary, secondary or early Benzathine penicillin G - 2.4 million units IM x 1 Late, latent, and indeterminate length, tertiary Benzathine penicillin G - 2.4 million units IM weekly x 3 weeks Penicillin allergic Doxycycline 100 mg p.o. BID or Erythromycin 500 mg p.o. QID Report to health department ©2009 Barkley & Associates 9.3.42 Chancroid ©2009 Barkley & Associates Chancroid Cause: Hemophilus ducreyi, a gram-negative bacillus Symptoms Women - usually asymptomatic Men - single (though may be multiple) superficial, painful ulcer, surrounded by an erythematous halo Ulcers may be necrotic or severely erosive ©2009 Barkley & Associates Chancroid: Diagnosis Probable diagnosis is usually a matter of exclusion Involves genitalia and unilateral bubo (or both) Painful genital ulcers in absence of T. pallidum and HSV (by inspection or culture) with coexisting tender inguinal lymphadenopathy is suggestive of chancroid Definitive diagnosis of chancroid is made morphologically, though the sensitivity of the test is no greater than 80% ©2009 Barkley & Associates 9.3.42 ©2009 Barkley & Associates Chancroid: Treatment Azithromycin (Zithromax) 1 gm p.o. x 1 dose OR Ceftriaxone (Rocephin) 250 mg IM x 1 dose OR Ciprofloxacin (Cipro) 500 mg p.o. BID x 3 days OR Erythromycin 500 mg p.o. QID x 7 days HIV + patients need a longer course of therapy ©2009 Barkley & Associates Lymphogranuloma Venereum (LGV) Cause: Immunotypes L1, L2 or L3 of Chlamydia trachomatis Prevalence: Endemic in Asia, Africa and large cities in the United States ©2009 Barkley & Associates 9.3.42 LGV: Symptoms 2 to 3 mm painless vesicle, bubo or nonindurated ulcer Regional adenopathy follows in approximately one month Stiffness and aching in groin followed by unilateral swelling of inguinal region ©2009 Barkley & Associates Lymphogranuloma Venereum ©2009 Barkley & Associates LGV Diagnosis: May be confused with chancroid Definitive diagnosis requires isolating C. trachomatis from an appropriate specimen and confirming isolate as an LGV immunotype ©2009 Barkley & Associates 9.3.42 LGV Treatment: Doxycycline 100 mg p.o. BID x 21 days Erythromycin 500 mg p.o. QID x 21 days Aspirate buboes to prevent ulcerations ©2009 Barkley & Associates ©2009 Barkley & Associates www.NPcourses.com ©2009 Barkley & Associates 9.3.42 ~ THANK YOU ~ P.O. Box 69901 West Hollywood, CA 90069 310.684.3880 www.NPcourses.com ©2009 Barkley & Associates 9.3.42